Bio Briefs
Posted By
Recent Posts on This Topic | See All >
-
May 16, 2013 UA spin-off launches clinical trial -
May 06, 2013 UA, Glendale honored in Clinical Trial of the Year
-
Apr 15, 2013 First class of AACR Fellows named
-
Apr 15, 2013 Drugs effective against tumors, studies show
Share on Twitter
Share on Facebook
Email to a friend
Print Article
Scottsdale Healthcare-TGen clinical trial results signal advances against skin cancer
[Source: TGen] - Analyses of clinical trial results published today in the New England Journal of Medicine (NEJM) shows a potential new investigational therapy for advanced and metastatic basal cell skin cancer.
The study, conducted at TGen Clinical Research Service (TCRS) at Scottsdale Healthcare and two other sites appears to demonstrate tumor shrinkage and limited side effects. TCRS is a strategic alliance between the Translational Genomics Research Institute (TGen) and Scottsdale Healthcare.
These findings are significant because no proven therapy exists for advanced basal cell carcinoma (BCC). BCC is the most common cancer in the United States with about one million new cases diagnosed each year. Arizona has one of the highest incidences of skin cancer in the world.
The article appears on-line today and in the Sept. 17 print issue of NEJM.
For more information: Scottsdale Healthcare-TGen clinical trial results signal advances against skin cancer
Quick Links
- Arizona Biosciences Video
- Arizona BioMap
- Roadmap Progress Updates
- Reports & Multimedia
- Timeline: Arizona's Bio Growth
- Arizona Bio Orgs on Twitter
- Newsletter Signup
- Arizona Center for Civic Leadership
“A Bridge Crossed,” a brochure featuring the 2012 progress of Arizona’s Bioscience Roadmap, as well as "Performance Assessment 2002-12," featuring the latest bioscience sector data from Battelle Technology Partnership Practice, are now available.
